Business
AI summarySanofi researches, develops, manufactures, and markets therapeutic solutions across immunology and inflammation, rare diseases, neurology, oncology, and vaccines. Its vaccine portfolio includes pediatric, respiratory syncytial virus, and travel vaccines covering polio, pertussis, Hib, hepatitis A, typhoid, yellow fever, and rabies. The company maintains numerous research collaborations and licensing agreements focused on small molecules, protein degraders, antibody therapies, and genome editing. Formerly Sanofi-Aventis, it was incorporated in 1994 and is headquartered in Paris, France.